Arcadia Biosciences (NASDAQ:RKDA) Stock Passes Below 50-Day Moving Average – Time to Sell?

Arcadia Biosciences, Inc. (NASDAQ:RKDA) shares passed below its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of $0.60 and traded as low as $0.4501. Arcadia Biosciences shares last traded at $0.4797, with a volume of 34,400 shares.

Analysts Set New Price Targets

Separately, Weiss Ratings lowered shares of Arcadia Biosciences from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Thursday, June 25th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat, Arcadia Biosciences presently has an average rating of “Sell”.

Arcadia Biosciences Stock Performance

The stock has a 50-day simple moving average of $0.59 and a 200-day simple moving average of $1.02.

Arcadia Biosciences (NASDAQ:RKDA) last released its quarterly earnings data on Thursday, August 13th. The basic materials company reported ($2.09) EPS for the quarter, missing analysts’ consensus estimates of ($0.56) by ($1.53). The firm had revenue of $1.44 million during the quarter, compared to analysts’ expectations of $1.90 million. Arcadia Biosciences had a negative return on equity of 183.50% and a negative net margin of 234.53%.

About Arcadia Biosciences

Arcadia Biosciences, Inc, founded in 2002 and headquartered in Davis, California, is an agricultural biotechnology company dedicated to developing crops and food ingredients that promote health and sustainability. By harnessing advanced genomics and precision‐breeding technologies, Arcadia creates proprietary trait platforms designed to enhance crop performance, nutritional value, and resilience to environmental stressors. The company’s scientific expertise focuses on non-transgenic approaches, enabling the delivery of novel traits without introducing foreign DNA.

Arcadia’s operations span two main segments: Crop Traits and Food Ingredients.